134 related articles for article (PubMed ID: 12570724)
1. Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists.
Dalpiaz A; Spisani S; Biondi C; Fabbri E; Nalli M; Ferretti ME
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):33-42. PubMed ID: 12570724
[TBL] [Abstract][Full Text] [Related]
2. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues.
Derian CK; Solomon HF; Higgins JD; Beblavy MJ; Santulli RJ; Bridger GJ; Pike MC; Kroon DJ; Fischman AJ
Biochemistry; 1996 Jan; 35(4):1265-9. PubMed ID: 8573582
[TBL] [Abstract][Full Text] [Related]
4. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
[No Abstract] [Full Text] [Related]
5. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
[TBL] [Abstract][Full Text] [Related]
6. Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin.
Miettinen HM; Gripentrog JM; Jesaitis AJ
J Cell Sci; 1998 Jul; 111 ( Pt 14)():1921-8. PubMed ID: 9645940
[TBL] [Abstract][Full Text] [Related]
7. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils.
Brazil TJ; Rossi AG; Haslett C; McGorum B; Dixon PM; Chilvers ER
J Leukoc Biol; 1998 Mar; 63(3):380-8. PubMed ID: 9500527
[TBL] [Abstract][Full Text] [Related]
8. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
[TBL] [Abstract][Full Text] [Related]
9. High constitutive activity of the human formyl peptide receptor.
Wenzel-Seifert K; Hurt CM; Seifert R
J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
[TBL] [Abstract][Full Text] [Related]
10. Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils.
Dalpiaz A; Scatturin A
Mini Rev Med Chem; 2003 May; 3(3):167-73. PubMed ID: 12570833
[TBL] [Abstract][Full Text] [Related]
11. Formylpeptide receptor antagonists: structure and activity.
Dalpiaz A; Pecoraro R; Vertuani G; Spisani S; Rizzuti O; Fabbri E; Scatturin A
Boll Chim Farm; 1999 Mar; 138(3):44-8. PubMed ID: 10394703
[No Abstract] [Full Text] [Related]
12. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
Kim CD; Hong KW
J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
[TBL] [Abstract][Full Text] [Related]
13. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR.
Hartt JK; Barish G; Murphy PM; Gao JL
J Exp Med; 1999 Sep; 190(5):741-7. PubMed ID: 10477558
[TBL] [Abstract][Full Text] [Related]
14. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils.
Sengeløv H; Boulay F; Kjeldsen L; Borregaard N
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):473-9. PubMed ID: 8172608
[TBL] [Abstract][Full Text] [Related]
15. Stimulus-response uncoupling in the neutrophil. Adenosine A2-receptor occupancy inhibits the sustained, but not the early, events of stimulus transduction in human neutrophils by a mechanism independent of actin-filament formation.
Cronstein BN; Haines KA
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):631-5. PubMed ID: 1311169
[TBL] [Abstract][Full Text] [Related]
16. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells.
Cui YH; Le Y; Gong W; Proost P; Van Damme J; Murphy WJ; Wang JM
J Immunol; 2002 Jan; 168(1):434-42. PubMed ID: 11751990
[TBL] [Abstract][Full Text] [Related]
17. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
18. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor.
Gao JL; Lee EJ; Murphy PM
J Exp Med; 1999 Feb; 189(4):657-62. PubMed ID: 9989980
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
Fletcher MP; Stahl GL; Longhurst JC
J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
[TBL] [Abstract][Full Text] [Related]
20. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
